Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014028 220008490 1.64 8.6 Disease modification (D) 2017-11-09 2017-11-18 Cyclophosphamide TBI Allograft N N 220032149 CYCLOPHOSPHAMIDE
220014029 220008491 1.67 null Disease modification (D) 2012-04-24 2014-03-21 CYCLOPHOSPHAMIDE N N 220032150 CYCLOPHOSPHAMIDE
220014030 220008492 1.69 null Curative (C) 2014-03-28 2014-04-05 Triple Intrathecal N N 220032156 TRIPLE INTRATHECAL
220014032 220008499 null 63 Curative (C) null 2014-06-01 Methotrexate intrathecal N N 220032158 METHOTREXATE INTRATHECAL
220014033 220014602 0 81.2 null 2013-07-29 2013-07-29 BOSUTINIB N N 220032159 BOSUTINIB
220014034 220008508 0 90 Curative (C) 2018-03-19 2018-03-20 BOSUTINIB 2 null 220032161 BOSUTINIB
220014035 220014605 0.96 79.4 Curative (C) 2015-10-25 2015-10-25 AML Int Guide ADE 8+3+5 (2) 02 N 220032164 ADE
220014037 220017986 null 68 Not known (9) 2014-06-16 2015-05-21 FLAG 02 N 220032170 FLAG
220014038 220017986 0 null Curative (C) 2014-08-03 2014-08-03 CYCLOPHOSPHAMIDE + FLUDARABINE Y N 220032170 CYCLOPHOSPHAMIDE + FLUDARABINE
220014039 220008512 1.33 28.85 Curative (C) 2014-06-04 2017-11-15 IDARUBICIN + TRETINOIN N null 220032175 IDARUBICIN + TRETINOIN
220014040 220008512 1.55 null Curative (C) 2016-06-24 2016-06-26 ATG + Busulfan + Fludarabine N N 220032175 ATG + BUSULFAN + FLUDARABINE
220014041 220008513 1.68 null Curative (C) 2016-03-10 2016-03-10 BOSUTINIB Y N 220032180 BOSUTINIB
220014042 220008514 null null null 2018-04-24 2018-04-28 ATG + Busulfan + Fludarabine null N 220032181 ATG + BUSULFAN + FLUDARABINE
220014043 220008514 1.73 0 Not known (9) null 2016-09-28 BOSUTINIB N N 220032181 BOSUTINIB
220014044 220008515 0 null Disease modification (D) 2017-05-24 2017-06-09 FLAG 02 N 220032187 FLAG
220014045 220008515 1.71 127 Disease modification (D) 2017-11-10 2017-11-11 ATG + Busulfan + Fludarabine 2 null 220032187 ATG + BUSULFAN + FLUDARABINE
220014046 220008516 1.5 57.4 null 2013-03-16 2013-03-16 RUXOLITINIB 02 N 220032198 RUXOLITINIB
220014047 220008517 1.78 88 Disease modification (D) 2014-07-02 2014-07-02 FLAG 02 N 220032200 FLAG
220014048 220008517 1.69 29.3 Adjuvant (A) 2016-01-16 2016-01-16 Idarubicin+Tretinoin Spanish Crse4 N N 220032200 IDARUBICIN + TRETINOIN
220014049 220008517 1.65 null Curative (C) null 2018-04-12 AML16 DA 3+8 02 N 220032200 AML16 TRIAL
220014050 220008520 1.86 85.7 Curative (C) 2014-06-09 2014-06-09 IDARUBICIN + TRETINOIN Y N 220032224 IDARUBICIN + TRETINOIN
220014051 220008521 1.7 null Curative (C) 2015-08-27 2015-08-27 AML Int Guide ADE 8+3+5 (2) 2 N 220032225 ADE
220014052 220014611 null 65 Curative (C) 2014-08-21 2014-08-23 AML16 DA 2+5 02 N 220032225 AML16 TRIAL
220014053 220014612 1.55 89.6 Disease modification (D) 2017-07-22 2017-07-27 Triple Intrathecal 2 N 220032227 TRIPLE INTRATHECAL
220014054 220014612 1.57 71.45 Curative (C) 2015-12-09 2015-12-12 AML Int Guide ADE 8+3+5 (2) 01 N 220032227 ADE
220014055 220008526 1.69 88.8 Curative (C) 2015-08-27 2015-08-30 Triple / Double Intrathecal Therapy N N 220032236 TRIPLE INTRATHECAL
220014056 220008530 null 55 Curative (C) 2014-12-14 2014-12-14 CYCLOPHOSPHAMIDE N N 220032252 CYCLOPHOSPHAMIDE
220014057 220008531 1.82 98 Curative (C) 2017-01-23 2017-01-23 Triple Intrathecal N N 220032254 TRIPLE INTRATHECAL
220014058 220008531 1.82 null Curative (C) 2014-03-10 2014-04-10 AML Int Guide ADE 10+3+5 (1) N null 220032254 ADE
220014061 220008538 1.59 85 Curative (C) 2013-05-06 2013-05-22 AML Int Guide ADE 8+3+5 (2) N N 220032265 ADE
220014062 220008541 1.91 127 Curative (C) 2016-01-20 2016-01-20 ATG + Busulfan + Fludarabine N null 220032271 ATG + BUSULFAN + FLUDARABINE
220014063 220008542 1.65 55.8 Curative (C) 2013-07-29 2013-07-29 ATG + Busulfan + Fludarabine 2 null 220032272 ATG + BUSULFAN + FLUDARABINE
220014064 220008545 0 57.1 Curative (C) 2013-06-08 2013-07-13 FLAG N N 220032272 FLAG
220014065 220008545 0 75 Curative (C) 2017-07-17 2017-07-17 AML Int Guide ADE 8+3+5 (2) N N 220032272 ADE
220014066 220008547 1.72 null null 2016-03-30 2016-03-30 AML16 DA 3+8 02 N 220032287 AML16 TRIAL
220014067 220008548 1.68 85 Curative (C) 2015-09-26 2015-11-27 RUXOLITINIB Y null 220032288 RUXOLITINIB
220014068 220008549 1.8 0 Curative (C) 2014-12-30 2015-01-15 CYCLOPHOSPHAMIDE + FLUDARABINE 01 N 220032293 CYCLOPHOSPHAMIDE + FLUDARABINE
220014069 220008550 null 75 Curative (C) 2016-07-23 2016-07-24 Idarubicin+Tretinoin Spanish Crse4 99 N 220032293 IDARUBICIN + TRETINOIN
220014070 220008551 1.68 99 Disease modification (D) 2012-07-04 2015-09-21 FLAG N null 220032309 FLAG
220014071 220008552 1.77 78.2 Curative (C) 2017-10-29 2017-10-29 IDARUBICIN + TRETINOIN 02 N 220032313 IDARUBICIN + TRETINOIN
220014072 220008555 1.72 16.6 Curative (C) 2018-08-08 2018-08-10 Cyclophosphamide + Fludarabine IV N N 220032316 CYCLOPHOSPHAMIDE + FLUDARABINE
220014073 220008557 1.73 null Curative (C) 2016-10-15 2016-10-23 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220032316 CYCLOPHOSPHAMIDE + FLUDARABINE
220014074 220008558 1.59 67.8 Curative (C) 2017-05-13 2017-05-13 Triple Intrathecal N N 220032319 TRIPLE INTRATHECAL
220014075 220008559 1.6 null Palliative (P) 2014-06-18 2014-07-10 Cyclophosphamide TBI Allograft N N 220032328 CYCLOPHOSPHAMIDE
220014076 220008561 1.85 null Curative (C) 2016-08-01 2016-08-01 Cyclophosphamide+Fludara+TBI Allo 02 null 220032328 CYCLOPHOSPHAMIDE + FLUDARABINE
220014077 220008562 1.77 76.6 Disease modification (D) 2015-09-26 2015-10-03 Methotrexate intrathecal N N 220032331 METHOTREXATE INTRATHECAL
220014078 220008564 null 0 Disease modification (D) 2016-01-07 2016-01-08 Idarubicin+Tretinoin Spanish Crse1 N N 220032333 IDARUBICIN + TRETINOIN
220014079 220008565 1.6 33 Curative (C) 2014-12-01 2014-12-05 RUXOLITINIB N null 220032344 RUXOLITINIB
220014080 220008566 1.79 105 Curative (C) 2017-03-29 2017-05-02 AML16 DA 3+8 01 N 220032344 AML16 TRIAL
220014081 220008568 1.54 54.4 Curative (C) 2017-06-18 2017-08-05 Cyclophosphamide+Fludara+TBI Allo 2 N 220032350 CYCLOPHOSPHAMIDE + FLUDARABINE